Company Summary
EKH EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED
Services/Health Care Services
sSET
CG Report:   
 
  Data as of 22 Apr 2019  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
5.95 6.30 / 5.00 30.46 4.18 300.00 3,570.00 3,606.93 179.47 20.10
News
Date/Time Subject
26 Mar 2019 19:57   Publication of the 2019 Annual General Shareholders Meeting invitation on the company website
21 Mar 2019 19:43   Notification of the Resignation of Director
26 Feb 2019 09:14   Dividend Payment and 2019 Annual Ordinary General Meeting of Shareholders
25 Feb 2019 18:27   Dividend Payment and 2019 Annual Ordinary General Meeting of Shareholders
25 Feb 2019 18:26   Financial Statement Yearly 2018 (Audited)
more

Company Profile
Address 99/9 Moo 4, Ekachai Road, Khok-kham, Muang Samutsakhon, Samut Sakhon 74000
Telephone 0-3441-7999 หรือ 1715
Fax 0-3441-7903
URL www.ekachaihospital.com
  Annual Report 2018
Establish Date 2003 Listed Date 27/07/2016
IPO Price (Baht) 3.05 @Par0.50 Baht
IPO Financial Advisory
  • FINANSIA SYRUS SECURITIES PUBLIC COMPANY LIMITED
  • Par 0.50 Baht
    Last Par Change N/A

    Business
    The company operates the overnight general hospital under the name of "Ekachai Hospital".

    Free Float 13 Mar 2018 15 Mar 2017
    % /Shareholders
    56.29% 4,373 56.35% 5,174
    Foreign Shareholders
     -
    Foreign Limit 49.00%
    NVDR Shareholders  0.15% (As of 22/04/2019)
    5 Yr Price Performance (Adjusted Price)
    Price Performance (Adjusted Price) Compare to Stock (%) Compare to Sector (%) Compare to Market (%)
    5 Days 5.31 3.96 4.40
    20 Days 7.21 4.74 5.47
    60 Days 10.19 3.03 5.46
    120 Days 2.59 4.65 1.67
    YTD 10.19 7.95 2.97
    P/E (X) 30.46 36.96 17.50
    P/BV (X) 4.18 4.91 1.86
    Turnover Ratio (%) 0.24 0.22 0.66

    Top 10 Major Shareholders(@12 Mar 2019) Share %
    1. นาง อรสา ตั้งสัจจะพจน์ 34,310,480 5.72
    2. นาย อำนวย เอื้ออารีมิตร 26,402,900 4.40
    3. นาย สุพร ปัญญาสาคร 21,172,640 3.53
    4. นาย ชาญชัย ตั้งสัจจะพจน์ 20,520,000 3.42
    5. นาย กิตติพัฒน์ เอื้ออารีมิตร 20,305,000 3.38
    6. น.ส. นิษฐา เอื้ออารีมิตร 19,760,000 3.29
    7. นาย วรวุฒิ เอื้ออารีมิตร 19,760,000 3.29
    8. นาง กาญจนา เอื้ออารีมิตร 18,236,600 3.04
    9. นาย สุทธิพงศ์ ตั้งสัจจะพจน์ 12,271,000 2.05
    10. น.ส. อลิสา สินพัฒนสกุล 11,080,000 1.85

    Management Position
    1. ADM. SURASAK ROUNROENGROM CHAIRMAN / INDEPENDENT DIRECTOR
    2. Mrs. ORASA TANGSAJJAPOJ DIRECTOR
    3. Mr. AMNUAY OERAREEMITR DIRECTOR
    4. Mrs. KANCHANA OERAREEMITR DIRECTOR
    5. Mr. SUTHIPONG TANGSAJJAPOJ DIRECTOR
    6. Mr. WANLOP POPIENTONG DIRECTOR
    7. Mr. AMNAJ EUR-AREEMITR DIRECTOR
    8. Mr. SURIN KOOCHAROENPRASIT INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE
    9. Mr. WORAPOL WIRIYAKULAPONG INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    10. Mr. VUTHICHAI TUMASAROJ INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    Accumulated: Turnover Ratio, Value Trade/Day
    Statistics YTD
    22 Apr 2019
    2018
    28 Dec 2018
    2017
    29 Dec 2017
    Listed share (M.) 600.00  600.00  600.00 
    Market Cap (MB.) 3,570.00  3,240.00  3,180.00 
    Price (B./share) 5.95  5.40  5.30 
    BVPS (B./Share) 1.43  1.38  1.32 
    P/BV (X) 4.18  3.91  4.02 
    P/E (X) 30.46  29.03  40.30 
    Turnover Ratio (%) 8.19  46.33  74.84 
    Value Trade/Day (MB.) 3.64  6.49  11.26 
    Beta 0.59  0.50  0.60 
     
    Rate of Return YTD  2018  2017 
    Price Change (%) 10.19  1.89  -24.29 
    Dividend Yield (%) 2.77  2.22  1.89 
    Payout Ratio 0.61  0.65  0.76 
    Dividend Policy At least 40% of its net profit after deduction of corporate retained loss (if any) and legal reserve (with additional conditions)

    Dividend
    Operation Period Dividend/Share Unit Payment Date Type
    01 Jan 2017 - 31 Dec 2017 0.12 Baht 16 May 2018 Cash
    01 Jan 2016 - 31 Dec 2016 0.10 Baht 16 May 2017 Cash
     
    Auditor
    (Effective Until 31/12/2019)
    MISS SUMALEE REEWARABUNDIT/E Y OFFICE COMPANY LIMITED
    MR. TERMPHONG OPANAPHAN/E Y OFFICE COMPANY LIMITED
    Miss VILAILAK LAOHASRISAKUL/E Y OFFICE COMPANY LIMITED
    F/S Year ended 31/12
    Latest Type of Report Unqualified opinion
    Financial Data
    Statement of Financial Position (MB.) 2018 
    (01/01/18 
    -31/12/18) 
    2017 
    (01/01/17 
    -31/12/17) 
    2016 
    (01/01/16 
    -31/12/16) 
    2015 
    (01/01/15 
    -31/12/15) 
    Cash 76.29 70.16 139.68 18.14
    A/R Net 69.27 52.59 48.42 37.05
    Inventories 16.44 12.06 11.91 10.89
    Current Assets 458.21 347.86 428.11 67.57
    PP&E Net 418.42 316.47 254.82 237.80
    Total Assets 968.30 900.31 877.62 310.41
    OD - - - -
    A/P Net 72.96 62.65 71.42 49.27
    Current portion of LT - - - 12.80
    Current Liabilities 96.84 70.83 85.90 77.62
    Non-Current Liabilities 9.47 6.34 4.34 3.32
    Total Liabilities 106.31 77.17 90.24 80.94
    Authorized Capital 300.00 300.00 300.00 216.60
    Paid-Up Capital 300.00 300.00 300.00 216.60
    Premium (Discount) on Share Capital 410.99 411.42 411.42 -
    Other Surplus (Deficit) 0.00 0.58 - -
    Retained Earnings (Deficit) 144.09 98.88 76.23 12.88
    Treasury Stock - - - -
    Shareholders' Equity 855.08 810.88 787.38 229.48
    Minority Interest 6.92 12.25 - -
    more
    Statement of Comprehensive Income (MB.) 2018 
    (01/01/18 
    -31/12/18) 
    2017 
    (01/01/17 
    -31/12/17) 
    2016 
    (01/01/16 
    -31/12/16) 
    2015 
    (01/01/15 
    -31/12/15) 
    Sales 638.12 522.98 502.13 431.44
    Other Income 16.17 18.00 9.85 7.17
    Total Revenues 654.29 540.98 511.98 438.61
    COGs 382.14 339.01 325.16 292.50
    SG&A 128.42 99.88 93.41 82.42
    Total Expenses 510.57 438.89 418.57 374.92
    EBITDA 179.47 131.82 118.68 91.04
    Depre. & Amor. 35.74 29.73 25.28 27.35
    EBIT 143.72 102.09 93.40 63.68
    Net Profit 117.21 83.83 75.27 48.57
    EPS (B.) 0.19 0.14 0.15 2.24
    more
    Statement of Cash Flow (MB.) 2018 
    (01/01/18 
    -31/12/18) 
    2017 
    (01/01/17 
    -31/12/17) 
    2016 
    (01/01/16 
    -31/12/16) 
    2015 
    (01/01/15 
    -31/12/15) 
    Operating Cash Flow 145.41 107.58 87.97 76.54
    Investing Cash Flow -61.28 -129.99 -432.93 -9.18
    Financing Cash Flow -78.00 -47.10 466.50 -53.66
    Net Cash Flow 6.13 -69.52 121.54 13.70
    more
    Annualized: ROE, ROA
    Ratios 2018  2017  2016 
    Current Ratio (X) 4.73 4.91 4.98
    ROE (%) 14.07 10.49 14.80
    ROA (%) 15.38 11.48 15.72
    D/E (X) 0.12 0.10 0.11
    Total Asset Turnover (X) 0.70 0.61 0.86
    Gross Profit Margin (%) 40.11 35.18 35.24
    EBIT Margin (%) 21.97 18.87 18.24
    Net Profit Margin (%) 17.91 15.50 14.70

    Information only PP, PO, XR and XD
    Capital Movement (Last 3 Year)
    Date CA Type Changed paid up share Paid up share Par
    No Information Found

    Growth Rate (%) 2018  2017  2016 
    Sales Growth 22.02 4.15 N/A
    COGs Growth 12.72 4.26 N/A
    Total Revenue Growth 20.94 5.67 N/A
    Total Expense Growth 16.33 4.85 N/A
    Net Profit Growth 39.82 11.37 N/A

    Annualized
    Cash Cycle 2018  2017  2016 
    A/R Turnover (Times) 10.47 10.35 11.75
    Avg. Collection Period (Days) 34.85 35.25 31.07
    Inventory Turnover (Times) 26.82 28.28 28.52
    Avg. Inventory Period (Days) 13.61 12.91 12.80
    A/P Turnover (Times) 5.64 5.06 5.39
    Avg. Payment Period (Days) 64.76 72.17 67.74
    Cash Cycle (Days) -16.30 -24.02 -23.87


    Trading Sign (Latest)
    Trading Alert Posted Date Lifted Date
    No Information Found

    Market Alert (Latest)
    No Information Found
    more

    Only Preferred Share and Warrants
    Other Securities
    Securities Name -

    Remark - Calculated from adjusted price
      - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
      - The information is quarterly updated within 7 business days after the new financial statement is submitted.
      -
     
    Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
    Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
    The Information is provided for informative and educational purposes only.